Ourania Kostopoulou

Artiklar

Article: BIOMEDICINE & PHARMACOTHERAPY. 2024;180:117500
Enhancing targeted therapy by combining PI3K and AKT inhibitors with or without cisplatin or vincristine in medulloblastoma cell lines in vitro
Lukoseviciute M; Need E; Birgersson M; Dalianis T; Kostopoulou ON
Article: BIOMEDICINE & PHARMACOTHERAPY. 2024;177:116993
Combined targeted therapy with PI3K and CDK4/6, or FGFR inhibitors show synergistic effects in a neuroblastoma spheroid culture model
Lukoseviciute M; Need E; Holzhauser S; Dalianis T; Kostopoulou ON
Article: ANTICANCER RESEARCH. 2024;44(5):1863-1876
Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Article: ORAL ONCOLOGY. 2024;151:106749
Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylha C; Marklund L; Nasman A; Sivars L; Dalianis T
Article: ONCOLOGY REPORTS. 2023;50(3):166
Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines
Lukoseviciute M; Holzhauser S; Pappa E; Mandal T; Dalianis T; Kostopoulou ON
Article: ONCOLOGY REPORTS. 2023;49(6):125
Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma
Lukoseviciute M; Theodosopoulou A; Holzhauser S; Dalianis T; Kostopoulou ON
Article: CANCERS. 2023;15(7):1954
High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma
de Flon CH; Haeggblom L; Holzhauser S; Kostopoulou ON; Zupancic M; Dalianis T; Munck-Wikland E; Marklund L; Nasman A
Article: CANCERS. 2022;15(1):93
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
Byskata K; Lukoseviciute M; Tuti F; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Article: VIRUSES-BASEL. 2022;14(7):1372
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors
Kostopoulou ON; Zupancic M; Pont M; Papin E; Lukoseviciute M; Mikelarena BA; Holzhauser S; Dalianis T
Article: MICROORGANISMS. 2021;9(6):1137
Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells
Yaiw K-C; Mohammad A-A; Taher C; Cui HL; Costa H; Kostopoulou ON; Jung M; Assinger A; Wilhelmi V; Yang J; Straat K; Rahbar A; Pernow J; Soderberg-Naucler C
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(7):3664
Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines
Jonsson LO; Sahi M; Lopez-Lorenzo X; Keller FL; Kostopoulou ON; Herold N; Ahrlund-Richter L; Fard SS
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2021;58(2):211-225
Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines
Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickstrom M; Kostopoulou ON; Dalianis T
Article: FRONTIERS IN ONCOLOGY. 2021;11:640490
Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations
Holzhauser S; Wild N; Zupancic M; Ursu RG; Bersani C; Nasman A; Kostopoulou ON; Dalianis T
Article: FRONTIERS IN ONCOLOGY. 2021;11:748657
Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines
Lukoseviciute M; Maier H; Poulou-Sidiropoulou E; Rosendahl E; Holzhauser S; Dalianis T; Kostopoulou ON
Article: BIOLOGY-BASEL. 2020;9(3):E44-44
Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer
Rahbar A; AlKharusi A; Costa H; Pantalone MR; Kostopoulou ON; Cui HL; Carlsson J; Radestad AF; Soderberg-Naucler C; Norstedt G
Article: ANTICANCER RESEARCH. 2020;40(1):53-66
Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines
Holzhauser S; Lukoseviciute M; Andonova T; Ursu RG; Dalianis T; Wickstrom M; Kostopoulou ON
Article: ONCOLOGY LETTERS. 2019;18(6):6249-6260
In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines
Holzhauser S; Kostopoulou ON; Ohmayer A; Lange BKA; Ramqvist T; Andonova T; Bersani C; Wickstrom M; Dalianis T
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2019;55(6):1372-1384
Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines
Kostopoulou ON; Holzhauser S; Lange BKA; Ohmayer A; Andonova T; Bersani C; Wickstrom M; Dalianis T
Article: TRANSLATIONAL ONCOLOGY. 2018;11(6):1292-1300
Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer
Radestad AF; Estekizadeh A; Cui HL; Kostopoulou ON; Davoudi B; Hirschberg AL; Carlson J; Rahbar A; Soderberg-Naucler C
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(6):1266-1276
Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance
Kostopoulou ON; Mohammad A-A; Bartek JJ; Winter J; Jung M; Stragliotto G; Soderberg-Naucler C; Landazuri N
Article: ONCOTARGET. 2017;8(57):96536-96552
Human cytomegalovirus and Herpes Simplex type I virus can engage RNA polymerase I for transcription of immediate early genes
Kostopoulou ON; Wilhelmi V; Raiss S; Ananthaseshan S; Lindstrom MS; Bartek J; Soderberg-Naucler C
Article: ONCOTARGET. 2016;7(30):47221-47231
Human cytomegalovirus may promote tumour progression by upregulating arginase-2
Costa H; Xu X; Overbeek G; Vasaikar S; Patro CPK; Kostopoulou ON; Jung M; Shafi G; Ananthaseshan S; Tsipras G; Davoudi B; Mohammad A-A; Lam H; Straat K; Wilhelmi V; Shang M; Tegner J; Tong JC; Wong KT; Soderberg-Naucler C; Yaiw K-C
Article: JOURNAL OF GENERAL VIROLOGY. 2015;96(12):3598-3612
Direct infection of primary endothelial cells with human cytomegalovirus prevents angiogenesis and migration
Gustafsson RKL; Jeffery HC; Yaiw K-C; Wilhelmi V; Kostopoulou ON; Davoudi B; Rahbar A; Benard M; Renne T; Soderberg-Naucler C; Butler LM
Article: BIOORGANIC & MEDICINAL CHEMISTRY. 2015;23(13):3163-3174
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Magoulas GE; Kostopoulou ON; Garnelis T; Athanassopoulos CM; Kournoutou GG; Leotsinidis M; Dinos GP; Papaioannou D; Kalpaxis DL
Article: JOURNAL OF ENDOUROLOGY. 2015;29(5):580-589
Evaluation of the distribution of Paclitaxel by immunohistochemistry and nuclear magnetic resonance spectroscopy after the application of a drug-eluting balloon in the porcine ureter.
Liourdi D; Kallidonis P; Kyriazis I; Tsamandas A; Karnabatidis D; Kitrou P; Spyroulias GA; Kostopoulou ON; Marousis K; Kalpaxis DL; Goumenos DS; Liatsikos E
Article: PLOS ONE. 2015;10(8):e0134526
Synthesis and Evaluation of Chloramphenicol Homodimers: Molecular Target, Antimicrobial Activity, and Toxicity against Human Cells
Kostopoulou ON; Magoulas GE; Papadopoulos GE; Mouzaki A; Dinos GP; Papaioannou D; Kalpaxis DL
Article: NUCLEIC ACIDS RESEARCH. 2014;42(13):8621-8634
Conjugation with polyamines enhances the antibacterial and anticancer activity of chloramphenicol.
Kostopoulou ON; Kouvela EC; Magoulas GE; Garnelis T; Panagoulias I; Rodi M; Papadopoulos G; Mouzaki A; Dinos GP; Papaioannou D; Kalpaxis DL
Article: PHARMAZIE. 2013;68(7):616-621
Clindamycin binding to ribosomes revisited: foot printing and computational detection of two binding sites within the peptidyl transferase center.
Kostopoulou ON; Papadopoulos G; Kouvela EC; Kalpaxis DL
Article: NUCLEIC ACIDS RESEARCH. 2012;40(11):5078-5087
Investigating the entire course of telithromycin binding to Escherichia coli ribosomes.
Kostopoulou ON; Petropoulos AD; Dinos GP; Choli-Papadopoulou T; Kalpaxis DL
Journal article: OPEN ENZYME INHIBITION JOURNAL. 2011;4(1):1-10
Insights into the Chloramphenicol Inhibition Effect on Peptidyl Transferase Activity, Using Two New Analogs of the Drug
Kostopoulou ON
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2010;35(3):235-239
Dissecting the ribosomal inhibition mechanism of a new ketolide carrying an alkyl-aryl group at C-13 of its lactone ring.
Krokidis MG; Kostopoulou ON; Kalpaxis DL; Dinos GP
Visa fler

Alla övriga publikationer

Review: ANTICANCER RESEARCH. 2023;43(9):3829-3839
New Approaches Towards Targeted Therapy for Childhood Neuroblastoma
Dalianis T; Lukoseviciute M; Holzhauser S; Kostopoulou ON
Review: VIRUSES-BASEL. 2021;13(5):910
Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma
Nasman A; Holzhauser S; Kostopoulou ON; Zupancic M; Ahrlund-Richter A; Du J; Dalianis T
Review: ANTICANCER RESEARCH. 2021;41(4):1715-1726
New Approaches in Targeted Therapy for Medulloblastoma in Children
Maier H; Dalianis T; Kostopoulou ON

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI